Overview
Bacteria are a major cause of contamination in food and water-borne diseases. To eliminate and treat bacterial infections many drugs are formulated and synthesized. Chemicals synthesized as potential anti microbial compounds and/or therapeutic drugs need to be tested for their efficacy. To do this, a good screening system with a test bacteria is essential.Researchers at the University of Maryland, College Park’s Department of Microbiology have developed a bacterial strain which can be used to screen for new anti microbial compounds. The advantage of this new invention over other currently existing technology involves a mutation in the bacteria which allows many more molecules to permeate or enter the cells. This invention thus allows for a more defined system to screen existing and new compounds for their anti microbial activity and assessment of their potential as new targets for drug development.
For additional information please contact the Office of Technology Commercialization, College Park, MD, . Phone (301) 405-3947. E-mail: [email protected].
Contact Info
UM Ventures
0134 Lee Building
7809 Regents Drive
College Park, MD 20742
Email: [email protected]
Phone: (301) 405-3947 | Fax: (301) 314-9502